policy-and-geopolitics1 hour ago
Treasury Proposes Sweeping Curbs on U.S. Investment in Chinese Biotech and AI
The U.S. Treasury Department has proposed new regulations to restrict American investment in sensitive Chinese technologies, including biotechnology, artificial intelligence, and hypersonic systems. This move, implementing the 2025 Comprehensive Outbound Investment National Security Act, aims to prevent adversaries from leveraging U.S. capital for military or surveillance capabilities. While the rules target advanced bio-derived compounds and brain-computer interfaces, they exclude certain cash-based licensing deals, sparking debate between national security advocates and the pharmaceutical industry.